Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T16:16:02.852Z.
Calculation as of: 2026-10-06T16:16:02.852Z.
Quote observation: 2026-10-06T16:15:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3557795f844472894604fcbd35c20595803ff4fe2165ab850e9e673e91650e7f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$31.77M
EBITDA Yield
7.74%
TTM Avg
3.91%
3Y Avg
10.09%
5Y Avg
10.18%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | $30.32M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.68M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.62M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.89M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.09M | N/A | 392.49% | 233.09% | 233.09% |
| OneMedNet Corporation (ONMD)vs › | $29.66M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 7.74% | 3.91% | 10.09% | 10.18% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.75M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
